Low Dose Naltrexone in Conjunction With the Wahls Protocol to Reduce the Frequency of Chronic Migraines in a Patient With Multiple Sclerosis: A Case Study

Integr Med (Encinitas)
20 June 2021
https://pubmed.ncbi.nlm.nih.gov/34377098/

Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells

Int J Mol Sci
05 Aug 2021
https://pubmed.ncbi.nlm.nih.gov/34445130/

Dr Richard Nahas, LDN Radio Show 12 April 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Richard Nahas shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Rajka Milanovic Galbraith, LDN Radio Show 16 Aug 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Rajka shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood. 

Dr Paul Anderson, LDN Radio Show 19 May 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Paul Anderson shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Paul Anderson, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Paul Anderson shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Patrick Callas, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Patrick Callas shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

What is the evidence behind potential Low Dose Naltrexone benefits?

California News Times
August 2021
https://californianewstimes.com/what-is-the-evidence-behind-potential-low-dose-naltrexone-benefits/493747/

Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells

Int J Mol Sci
August 2021
Int J Mol Sci. 2021 Aug 5;22(16):8429. doi: 10.3390/ijms22168429